A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
Biliary tract cancers (BTCs) are rare and lethal cancers, with a 5-year survival inferior to 20%(1-3). The only potential curative treatment is surgical resection. However, despite complex surgical procedures that have a remarkable risk of postoperative morbidity and mortality, the 5-year survival r...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2024
|
| In: |
BMC cancer
Year: 2024, Jahrgang: 24, Heft: 1, Pages: [1]-10 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/s12885-024-12225-6 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-024-12225-6
|
| Verfasserangaben: | Monica Niger, Federico Nichetti, Lorenzo Fornaro, Chiara Pircher, Federica Morano, Federica Palermo, Lorenza Rimassa, Tiziana Pressiani, Rossana Berardi, Andrea Casadei Gardini, Elisa Sperti, Lisa Salvatore, Davide Melisi, Francesca Bergamo, Salvatore Siena, Stefania Mosconi, Raffaella Longarini, Giuseppina Arcangeli, Salvatore Corallo, Laura Delliponti, Stefano Tamberi, Elena Fea, Giovanni Brandi, Ilario Giovanni Rapposelli, Massimiliano Salati, Paolo Baili, Rosalba Miceli, Silva Ljevar, Ilaria Cavallo, Elisa Sottotetti, Antonia Martinetti, Michele Droz Dit Busset, Carlo Sposito, Maria Di Bartolomeo, Filippo Pietrantonio, Filippo de Braud and Vincenzo Mazzaferro |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1907762566 | ||
| 003 | DE-627 | ||
| 005 | 20241220171139.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241106s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12885-024-12225-6 |2 doi | |
| 035 | |a (DE-627)1907762566 | ||
| 035 | |a (DE-599)KXP1907762566 | ||
| 035 | |a (OCoLC)1475637253 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Niger, Monica |e VerfasserIn |0 (DE-588)1347421025 |0 (DE-627)190776335X |4 aut | |
| 245 | 1 | 2 | |a A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence |b PURITY study |c Monica Niger, Federico Nichetti, Lorenzo Fornaro, Chiara Pircher, Federica Morano, Federica Palermo, Lorenza Rimassa, Tiziana Pressiani, Rossana Berardi, Andrea Casadei Gardini, Elisa Sperti, Lisa Salvatore, Davide Melisi, Francesca Bergamo, Salvatore Siena, Stefania Mosconi, Raffaella Longarini, Giuseppina Arcangeli, Salvatore Corallo, Laura Delliponti, Stefano Tamberi, Elena Fea, Giovanni Brandi, Ilario Giovanni Rapposelli, Massimiliano Salati, Paolo Baili, Rosalba Miceli, Silva Ljevar, Ilaria Cavallo, Elisa Sottotetti, Antonia Martinetti, Michele Droz Dit Busset, Carlo Sposito, Maria Di Bartolomeo, Filippo Pietrantonio, Filippo de Braud and Vincenzo Mazzaferro |
| 264 | 1 | |c 2024 | |
| 300 | |a 1 Illustration | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 8. April 2024 | ||
| 500 | |a Gesehen am 06.11.2024 | ||
| 520 | |a Biliary tract cancers (BTCs) are rare and lethal cancers, with a 5-year survival inferior to 20%(1-3). The only potential curative treatment is surgical resection. However, despite complex surgical procedures that have a remarkable risk of postoperative morbidity and mortality, the 5-year survival rate after radical surgery (R0) is 20-40% and recurrence rates are up to ~ 75%(4-6). Up to ~ 40% of patients relapse within 12 months after resection, and half of these patient will recur systemically(4-6). There is no standard of care for neoadjuvant chemotherapy (NAC) in resectable BTC, but retrospective reports suggest its potential benefit (7, 8). | ||
| 650 | 4 | |a Biliary tract cancers | |
| 650 | 4 | |a Cholangiocarcinoma | |
| 650 | 4 | |a Cisplatin gemcitabine nabpaclitaxel | |
| 650 | 4 | |a Neoadjuvant chemotherapy | |
| 700 | 1 | |a Nichetti, Federico |e VerfasserIn |0 (DE-588)124556241X |0 (DE-627)1777258693 |4 aut | |
| 700 | 1 | |a Fornaro, Lorenzo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pircher, Chiara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Morano, Federica |e VerfasserIn |4 aut | |
| 700 | 1 | |a Palermo, Federica |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rimassa, Lorenza |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pressiani, Tiziana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berardi, Rossana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gardini, Andrea Casadei |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sperti, Elisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Salvatore, Lisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Melisi, Davide |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bergamo, Francesca |e VerfasserIn |4 aut | |
| 700 | 1 | |a Siena, Salvatore |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mosconi, Stefania |e VerfasserIn |4 aut | |
| 700 | 1 | |a Longarini, Raffaella |e VerfasserIn |4 aut | |
| 700 | 1 | |a Arcangeli, Giuseppina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Corallo, Salvatore |e VerfasserIn |4 aut | |
| 700 | 1 | |a Delliponti, Laura |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tamberi, Stefano |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fea, Elena |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brandi, Giovanni |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rapposelli, Ilario Giovanni |e VerfasserIn |4 aut | |
| 700 | 1 | |a Salati, Massimiliano |e VerfasserIn |4 aut | |
| 700 | 1 | |a Baili, Paolo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Miceli, Rosalba |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ljevar, Silva |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cavallo, Ilaria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sottotetti, Elisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Martinetti, Antonia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Busset, Michele Droz Dit |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sposito, Carlo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Di Bartolomeo, Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pietrantonio, Filippo |e VerfasserIn |4 aut | |
| 700 | 1 | |a de Braud, Filippo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mazzaferro, Vincenzo |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 24(2024), 1, Artikel-ID 436, Seite [1]-10 |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence PURITY study |
| 773 | 1 | 8 | |g volume:24 |g year:2024 |g number:1 |g elocationid:436 |g pages:[1]-10 |g extent:10 |a A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence PURITY study |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12885-024-12225-6 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241106 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 124556241X |a Nichetti, Federico |m 124556241X:Nichetti, Federico |p 2 | ||
| 999 | |a KXP-PPN1907762566 |e 461052080X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Niger, Monica","given":"Monica","family":"Niger"},{"family":"Nichetti","given":"Federico","roleDisplay":"VerfasserIn","display":"Nichetti, Federico","role":"aut"},{"role":"aut","display":"Fornaro, Lorenzo","roleDisplay":"VerfasserIn","given":"Lorenzo","family":"Fornaro"},{"roleDisplay":"VerfasserIn","display":"Pircher, Chiara","role":"aut","family":"Pircher","given":"Chiara"},{"role":"aut","display":"Morano, Federica","roleDisplay":"VerfasserIn","given":"Federica","family":"Morano"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Palermo, Federica","given":"Federica","family":"Palermo"},{"given":"Lorenza","family":"Rimassa","role":"aut","roleDisplay":"VerfasserIn","display":"Rimassa, Lorenza"},{"display":"Pressiani, Tiziana","roleDisplay":"VerfasserIn","role":"aut","family":"Pressiani","given":"Tiziana"},{"given":"Rossana","family":"Berardi","role":"aut","display":"Berardi, Rossana","roleDisplay":"VerfasserIn"},{"display":"Gardini, Andrea Casadei","roleDisplay":"VerfasserIn","role":"aut","family":"Gardini","given":"Andrea Casadei"},{"role":"aut","display":"Sperti, Elisa","roleDisplay":"VerfasserIn","given":"Elisa","family":"Sperti"},{"family":"Salvatore","given":"Lisa","roleDisplay":"VerfasserIn","display":"Salvatore, Lisa","role":"aut"},{"family":"Melisi","given":"Davide","roleDisplay":"VerfasserIn","display":"Melisi, Davide","role":"aut"},{"role":"aut","display":"Bergamo, Francesca","roleDisplay":"VerfasserIn","given":"Francesca","family":"Bergamo"},{"family":"Siena","given":"Salvatore","roleDisplay":"VerfasserIn","display":"Siena, Salvatore","role":"aut"},{"given":"Stefania","family":"Mosconi","role":"aut","roleDisplay":"VerfasserIn","display":"Mosconi, Stefania"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Longarini, Raffaella","given":"Raffaella","family":"Longarini"},{"role":"aut","display":"Arcangeli, Giuseppina","roleDisplay":"VerfasserIn","given":"Giuseppina","family":"Arcangeli"},{"given":"Salvatore","family":"Corallo","role":"aut","display":"Corallo, Salvatore","roleDisplay":"VerfasserIn"},{"display":"Delliponti, Laura","roleDisplay":"VerfasserIn","role":"aut","family":"Delliponti","given":"Laura"},{"given":"Stefano","family":"Tamberi","role":"aut","roleDisplay":"VerfasserIn","display":"Tamberi, Stefano"},{"display":"Fea, Elena","roleDisplay":"VerfasserIn","role":"aut","family":"Fea","given":"Elena"},{"given":"Giovanni","family":"Brandi","role":"aut","display":"Brandi, Giovanni","roleDisplay":"VerfasserIn"},{"family":"Rapposelli","given":"Ilario Giovanni","display":"Rapposelli, Ilario Giovanni","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Salati","given":"Massimiliano","display":"Salati, Massimiliano","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Baili, Paolo","role":"aut","family":"Baili","given":"Paolo"},{"display":"Miceli, Rosalba","roleDisplay":"VerfasserIn","role":"aut","family":"Miceli","given":"Rosalba"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Ljevar, Silva","given":"Silva","family":"Ljevar"},{"given":"Ilaria","family":"Cavallo","role":"aut","display":"Cavallo, Ilaria","roleDisplay":"VerfasserIn"},{"family":"Sottotetti","given":"Elisa","display":"Sottotetti, Elisa","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Martinetti, Antonia","roleDisplay":"VerfasserIn","role":"aut","family":"Martinetti","given":"Antonia"},{"role":"aut","display":"Busset, Michele Droz Dit","roleDisplay":"VerfasserIn","given":"Michele Droz Dit","family":"Busset"},{"given":"Carlo","family":"Sposito","role":"aut","display":"Sposito, Carlo","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Di Bartolomeo, Maria","roleDisplay":"VerfasserIn","given":"Maria","family":"Di Bartolomeo"},{"given":"Filippo","family":"Pietrantonio","role":"aut","display":"Pietrantonio, Filippo","roleDisplay":"VerfasserIn"},{"family":"de Braud","given":"Filippo","roleDisplay":"VerfasserIn","display":"de Braud, Filippo","role":"aut"},{"given":"Vincenzo","family":"Mazzaferro","role":"aut","display":"Mazzaferro, Vincenzo","roleDisplay":"VerfasserIn"}],"title":[{"title":"A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence","subtitle":"PURITY study","title_sort":"phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence"}],"language":["eng"],"recId":"1907762566","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online veröffentlicht: 8. April 2024","Gesehen am 06.11.2024"],"name":{"displayForm":["Monica Niger, Federico Nichetti, Lorenzo Fornaro, Chiara Pircher, Federica Morano, Federica Palermo, Lorenza Rimassa, Tiziana Pressiani, Rossana Berardi, Andrea Casadei Gardini, Elisa Sperti, Lisa Salvatore, Davide Melisi, Francesca Bergamo, Salvatore Siena, Stefania Mosconi, Raffaella Longarini, Giuseppina Arcangeli, Salvatore Corallo, Laura Delliponti, Stefano Tamberi, Elena Fea, Giovanni Brandi, Ilario Giovanni Rapposelli, Massimiliano Salati, Paolo Baili, Rosalba Miceli, Silva Ljevar, Ilaria Cavallo, Elisa Sottotetti, Antonia Martinetti, Michele Droz Dit Busset, Carlo Sposito, Maria Di Bartolomeo, Filippo Pietrantonio, Filippo de Braud and Vincenzo Mazzaferro"]},"id":{"doi":["10.1186/s12885-024-12225-6"],"eki":["1907762566"]},"origin":[{"dateIssuedDisp":"2024","dateIssuedKey":"2024"}],"relHost":[{"title":[{"title_sort":"BMC cancer","title":"BMC cancer"}],"part":{"year":"2024","pages":"[1]-10","issue":"1","text":"24(2024), 1, Artikel-ID 436, Seite [1]-10","volume":"24","extent":"10"},"pubHistory":["1.2001 -"],"language":["eng"],"recId":"326643710","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 22.05.20"],"disp":"A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence PURITY studyBMC cancer","id":{"eki":["326643710"],"zdb":["2041352-X"],"issn":["1471-2407"]},"origin":[{"publisherPlace":"London ; Berlin ; Heidelberg","publisher":"BioMed Central ; Springer","dateIssuedKey":"2001","dateIssuedDisp":"2001-"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"10 S."}]} | ||
| SRT | |a NIGERMONICPHASEIIIII2024 | ||